These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
515 related items for PubMed ID: 34674082
1. Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patients. Chen Z, Li Y, Wang Q, Weng S, Zhou Y, Zhu J. Clin Rheumatol; 2022 Mar; 41(3):839-846. PubMed ID: 34674082 [Abstract] [Full Text] [Related]
3. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Schönau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, Kuwert T, Schett G. Ann Rheum Dis; 2018 Jan; 77(1):70-77. PubMed ID: 28928271 [Abstract] [Full Text] [Related]
4. Predictors of Diagnostic Contributions and Spontaneous Remission of Symptoms Associated with Positron Emission Tomography with Fluorine-18-Fluorodeoxy Glucose Combined with Computed Tomography in Classic Fever or Inflammation of Unknown Origin: a Retrospective Study. Tsuzuki S, Watanabe A, Iwata M, Toyama H, Terasawa T. J Korean Med Sci; 2021 Jun 07; 36(22):e150. PubMed ID: 34100562 [Abstract] [Full Text] [Related]
5. 18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study. Wang Q, Li YM, Li Y, Hua FC, Wang QS, Zhang XL, Cheng C, Wu H, Yao ZM, Zhang WF, Hou QY, Miao WB, Wang XM. Eur J Nucl Med Mol Imaging; 2019 Jan 07; 46(1):159-165. PubMed ID: 30099578 [Abstract] [Full Text] [Related]
6. Combined clinical parameters improve the diagnostic efficacy of 18F-FDG PET/CT in patients with fever of unknown origin (FUO) and inflammation of unknown origin (IUO): A prospective study in China. Wang WX, Cheng ZT, Zhu JL, Xing MY, Zheng CF, Wang SJ, Xie NN, XianYu ZQ, Song JX. Int J Infect Dis; 2020 Apr 07; 93():77-83. PubMed ID: 31982625 [Abstract] [Full Text] [Related]
7. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ, Sheng GP, Yu HY, Huang HJ, Liu J, Xiang DR, Dong MJ, Zhao K, Li LJ. Eur J Intern Med; 2011 Feb 07; 22(1):112-6. PubMed ID: 21238906 [Abstract] [Full Text] [Related]
11. Current situation and cost-effectiveness of 18F-FDG PET/CT for the diagnosis of fever of unknown origin and inflammation of unknown origin: A single-center, large-sample study from China. Chen JC, Wang Q, Li Y, Zhao YY, Gao P, Qiu LH, Hao KJ, Li HB, Yue MG, Zhou YS, Zhu JH, Gao Y, Gao ZC. Eur J Radiol; 2022 Mar 07; 148():110184. PubMed ID: 35121332 [Abstract] [Full Text] [Related]
12. Contribution of 18F-FDG PET/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: a meta-analysis. Kan Y, Wang W, Liu J, Yang J, Wang Z. Acta Radiol; 2019 Jun 07; 60(6):716-725. PubMed ID: 30205705 [Abstract] [Full Text] [Related]
13. EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin. Hess S, Noriega-Álvarez E, Leccisotti L, Treglia G, Albano D, Roivainen A, Glaudemans AWJM, Gheysens O. Eur J Nucl Med Mol Imaging; 2024 Jul 07; 51(9):2597-2613. PubMed ID: 38676736 [Abstract] [Full Text] [Related]
15. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study. Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S. HIV Med; 2013 Sep 07; 14(8):455-62. PubMed ID: 23517190 [Abstract] [Full Text] [Related]
16. 18 F-FDG-PET/CT as adjunctive diagnostic modalities in canine fever of unknown origin. Grobman M, Cohn L, Knapp S, Bryan JN, Reinero C. Vet Radiol Ultrasound; 2018 Jan 07; 59(1):107-115. PubMed ID: 28925085 [Abstract] [Full Text] [Related]
18. Diagnostic performance of 18 F-FDG-PET/CT in inflammation of unknown origin: A clinical series of 317 patients. Holubar J, Broner J, Arnaud E, Hallé O, Mura T, Chambert B, Sotto A, Roubille C, Gaujoux-Viala C, Goulabchand R. J Intern Med; 2022 Jun 07; 291(6):856-863. PubMed ID: 35018669 [Abstract] [Full Text] [Related]